Skip to search formSkip to main contentSkip to account menu

SCA 40

Known as: SCA-40, SCA40 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Asthma is a complex disease characterised by bronchoconstriction and airways inflammation. Recent advances in medicinal chemistry… 
1997
1997
There is currently interest in the use of inhibitors of cyclic nucleotide phosphodiesterases (PDE) as potential anti-asthma… 
1997
1997
Abstract SCA40 (6-bromo-8-methylaminoimidazo[1,2-a]- pyrazine-2-carbonitrile), a compound which had been described as an opener… 
1996
1996
1 SCA40 (0.1 nM‐0.1 mM) produced concentration‐dependent suppression of the spontaneous tone of human isolated bronchus (‐log… 
1996
1996
Phosphodiesterase (PDE) isoenzyme type IV is the predominant cyclic AMP hydrolytic activity in polymorphonuclear leukocytes (PMNs… 
1996
1996
Summary— The aim of this study was to examine the activity of SCA40, a novel charybdotoxin‐sensitive potassium channel opener… 
1993
1993
1 Experiments have been performed to investigate the cardiovascular actions in the rat of SCA40, a novel potassium channel opener…